Price T Rowe Associates Inc Amicus Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

  • $867 Billion
  • Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,368,641 shares of FOLD stock, worth $12.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,368,641
Previous 1,341,921 1.99%
Holding current value
$12.4 Million
Previous $14.3 Million 10.04%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$9.36 - $12.01 $250,099 - $320,907
26,720 Added 1.99%
1,368,641 $12.9 Million
Q3 2024

Nov 14, 2024
SELL
$9.55 - $12.09 $459,603 - $581,843
-48,126 Reduced 3.46%
1,341,921 $14.3 Million
Q2 2024

Aug 14, 2024
BUY
$9.04 - $11.75 $6,201 - $8,060
686 Added 0.05%
1,390,047 $13.8 Million
Q1 2024

May 15, 2024
BUY
$11.43 - $14.24 $137,194 - $170,922
12,003 Added 0.87%
1,389,361 $16.4 Million
Q4 2023

Feb 14, 2024
SELL
$9.97 - $14.52 $196,777 - $286,581
-19,737 Reduced 1.41%
1,377,358 $19.5 Million
Q3 2023

Nov 14, 2023
BUY
$11.78 - $13.86 $52,786 - $62,106
4,481 Added 0.32%
1,397,095 $17 Million
Q2 2023

Aug 14, 2023
SELL
$10.72 - $13.3 $818,879 - $1.02 Million
-76,388 Reduced 5.2%
1,392,614 $17.5 Million
Q1 2023

May 15, 2023
SELL
$10.91 - $13.54 $231,215 - $286,953
-21,193 Reduced 1.42%
1,469,002 $16.3 Million
Q4 2022

Feb 14, 2023
BUY
$9.89 - $12.7 $311,287 - $399,732
31,475 Added 2.16%
1,490,195 $18.2 Million
Q3 2022

Nov 14, 2022
SELL
$9.82 - $12.75 $71,440 - $92,756
-7,275 Reduced 0.5%
1,458,720 $15.2 Million
Q2 2022

Aug 15, 2022
BUY
$6.23 - $11.12 $30,302 - $54,087
4,864 Added 0.33%
1,465,995 $15.7 Million
Q1 2022

May 16, 2022
SELL
$7.89 - $12.48 $4.77 Million - $7.54 Million
-604,011 Reduced 29.25%
1,461,131 $13.8 Million
Q4 2021

Feb 14, 2022
SELL
$9.82 - $12.44 $6.99 Million - $8.86 Million
-712,106 Reduced 25.64%
2,065,142 $23.9 Million
Q3 2021

Nov 15, 2021
BUY
$8.74 - $11.84 $1.83 Million - $2.48 Million
209,572 Added 8.16%
2,777,248 $26.5 Million
Q2 2021

Aug 16, 2021
BUY
$8.71 - $10.72 $4.2 Million - $5.17 Million
482,004 Added 23.11%
2,567,676 $24.8 Million
Q1 2021

May 17, 2021
BUY
$9.2 - $23.86 $334,052 - $866,356
36,310 Added 1.77%
2,085,672 $20.6 Million
Q4 2020

Feb 16, 2021
BUY
$13.47 - $24.89 $27.6 Million - $51 Million
2,049,362 New
2,049,362 $47.3 Million

Others Institutions Holding FOLD

# of Institutions
312
Shares Held
311M
Call Options Held
467K
Put Options Held
515K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.55B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email